Who owns AKARI THERAPEUTICS PLC SPONSORED?
- Ticker: AKTX
- CUSIP Number: 00972g207
Tip: Access positions for across all investors
Analyze quarterly positions in Akari Therapeutics Plc Sponsored with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Akari Therapeutics Plc Sponsored stock
Who bought or sold AKARI THERAPEUTICS PLC SPONSORED this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Cresset Asset Management | 823k | $831k | 4368% | Sep 2025 |
|
| Palo Alto Investors | 146k | $148k | 0% | Sep 2025 |
|
| HighTower Advisors | 79k | $80k | 0% | Sep 2025 |
|
| Omnia Family Wealth | 28k | $29k | -55% | Sep 2025 |
|
| HPM Partners | 24k | $24k | 0% | Sep 2025 |
|
| Virtu Financial | 23k | $22k | 100% | Sep 2025 |
|
| Two Sigma Securities | 20k | $20k | 100% | Sep 2025 |
|
| Independent Advisor Alliance | 11k | $11k | 100% | Sep 2025 |
|
| Accent Capital Management | 10k | $10k | 0% | Sep 2025 |
|
| Goss Wealth Management | 6.8k | $6.9k | 0% | Sep 2025 |
|
| UBS Group | 60.00 | $61.002000 | -97% | Sep 2025 |
|
| Truvestments Capital | 50.00 | $51.000000 | 0% | Sep 2025 |
|
| EverSource Wealth Advisors | 44.00 | $44.000000 | -99% | Sep 2025 |
|
| Cornerstone Planning Group | 7.00 | $285.000100 | 40% | Sep 2025 |
|
| Morgan Stanley | 3.00 | $3.999900 | 100% | Jun 2025 |
|
Who sold out of Akari Therapeutics Plc Sponsored?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Sabby Management | Jun 2025 | 180k | $210k |
| Renaissance Technologies | Jun 2025 | 17k | $20k |